Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
If this hypothesis were to be confirmed, it could lead to a conflict regarding treatment because ACE2 reduces inflammation and has been suggested as a potential new therapy for inflammatory lung diseases, cancer, diabetes, and hypertension.
